Barely Significant
← all excerpts

Use of Different Anti-PD-1 Checkpoint Combination Strategies for First-Line Advanced NSCLC Treatment-The Experience of Ion Chiricuță Oncology Institute.

Cancers (Basel) · 2024 · PMC11171289 · PMID 38893141

Europe PMCDOI
1
hedged sentence
0.4100
closest p · 8.2× alpha
0.4100
boldest claim

The sentences

did not reach statistical significancep = 0.41not close (p > 0.1)
The difference between the PFS curves did not reach statistical significance ( p = 0.41, HR = 0.83 limits 0.75–0.92).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.